It sure seemed fishy that Merck would push the Boston legislature to mandate Gardasil HPV vaccines for all teenage girls in the state almost before the vaccine hit the streets. I am not one to experiment on my daughter. I doubt many parents will. But if there is a medicine with a proven track record of preventing serious disease, disease that she is likely to get without the medicine, then my husband and I will make sure she’s treated. But Gardasil is one big unknown.
Merck claimed it would prevent cervical cancer by targeting human papillomavirus. Turns out HPV is not a necessary precursor for all types of cervical cancer. Turns out Gardasil has some nasty side effects and now we know that Gardasil is causing death.
Normally, I’m 100% behind pharmaceutical companies. Their asthma medications have saved my life more than once. But this is appalling behavior, pushing an unproven medication on such a vulnerable slice of our society, pre-teen and teenage girls.
This from WorldNetDaily:
“Anaphylactic shock,” “foaming at mouth,” “grand mal convulsion,” “coma” and “now paralyzed” are a few of the startling descriptions included in a new federal report describing the complications from Merck & Co.’s Gardasil medication for sexually transmitted human papillomavirus – which has been proposed as mandatory for all schoolgirls.
The document was obtained from the U.S. Food and Drug Administration by Judicial Watch, a Washington group that investigates and prosecutes government corruption, and it has details of 10 deaths just since September.
“Given all the questions about Gardasil, the best public health policy would be to re-evaluate its safety and to prohibit its distribution to minors. In the least, governments should rethink any efforts to mandate or promote this vaccine for children,” said Judicial Watch President Tom Fitton.
The organization’s work uncovered reports of about one death each month since last fall, bringing the total death toll from the drug to at least 18 and as many as 20. There also were 140 “serious” reports of complications including about three dozen classified as life-threatening, 10 spontaneous abortions and half a dozen cases of Guillain-Barre Syndrome.
The document reveals the case of an 18-year-old woman who got the Gardasil vaccine, was found unconscious that evening, and died. Another woman, age 19, got the drug and the next morning was found dead in her bed.
The new documents also reveal a total of 8,864 Vaccine Adverse Event Reporting System records, up from a total of 3,461 that had been reported in a document just last fall.
WND previously has reported how Merck was lobbying state lawmakers to require the vaccination, but said it would quit the campaign after its activities were unveiled.
WND also reported when a key researcher into human papillomavirus, which is targeted by Gardasil, reported it needed more testing, and how even the Centers for Disease Control suggested the vaccine should not be mandatory.
That, however, has not diverted the building campaign to have legislatures adopt mandatory vaccination plans.
The target of the vaccine is cervical cancer, since studies show that those who have HPV have a higher chance of later developing cervical cancer. However, opponents note that such cancers develop most often in older women, while the plan is to require girls as young as 11 or 12 years old to be inoculated. They cite the lack of evidence that the vaccine would have an impact later in life.
A Judicial Watch report said, “Even though Gardasil will not be fully tested for safety until 2009, physicians are already pushing it as a routine, harmless vaccine. Merck’s aggressive advertisement campaign tells young girls that their lives could be ‘one less’ affected by cervical cancer and that, ‘It’s your turn to help guard against cervical cancer.’”
The report also estimated it will cost as much as $2 billion to buy vaccinations for the nation’s poorest girls.
“This vaccine will be more expensive than all other childhood vaccines put together,” concluded John Schiller, a National Cancer Institute investigator.
